CClinicalTrials.gg
CompletedNCT02728362Updated Oct 18, 2023

Suprapatellar Nailing of Tibial Shaft Fractures

An observational study in Broken Leg, sponsored by Spectrum Health Hospitals. Completed. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-10-18.

Sponsored by Spectrum Health Hospitals · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
38
Ages
18 Years to 65 Years
Sex
All
01

Study summary

To investigate the functional outcomes and prevalence and severity of knee pain for patients undergoing suprapatellar nailing of tibial shaft fractures.

Read the detailed description

Suprapatellar nailing...

Participants will be followed for 10 years prospectively. Follow up visits will occur at 2 weeks, 6weeks, 3 months, 6 months, 12 months, 3 years, 5 years, 7 years and 10 years.

Interim analysis will be done at 1, 3, 5, and 7 years with final analysis occuring at 10 years.

Primary and secondary endpoints in patients undergoing suprapatellar nailing of tibial shaft fractures are:

  1. To evaluate the long term presence of knee pain
  2. To evaluate the long term functional outcomes
02

Conditions studied

  • Broken Leg

Browse trials for

Keywords

  • tibial shaft fractures
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's enrollment of 38 is below the median of 100 across 675 observational studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Spectrum Health Hospitals is the lead sponsor of 38 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients presenting with tibial shaft fractures.

Inclusion criteria

  • Isolated, unilateral tibial shaft fractures
  • Orthopaedic Trauma Association (OTA) classification of 42 and may extend to 43A or 43B
  • age 18-65, including pregnant women
  • open or closed fractures
  • able to sign consent
  • english speaking

Exclusion criteria

Exclusion Criteria:

  • compartment syndrome
  • other lower extremity injuries that will affect functional outcomes
  • problems maintaining follow up (homeless, not willing to return for follow up)
  • pathological fractures
  • prisoners
  • previous retained hardware in the injured leg
  • injuries requiring vascular repair
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
38 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Long term presence of knee pain

    During follow up visits participants will be administered the Visual Analog Scale (VAS) and the Patient Reported Outcomes Measurement Information System (PROMIS) Pain intensity short form 3a and Pain interference short form 8a. These forms will be analyzed together to determine an overall presence of knee pain.

    Time frame: 10 years

Secondary outcomes

  1. Long term functional outcomes

    During follow up visits participants will be administered the Lysholm knee score and the PROMIS Mobility measure. These forms will be analyzed together to determine the overall long term function of the participants.

    Time frame: 10 years

  2. Knee Range of Motion (ROM)

    During follow up visits the participants knee ROM will be measured

    Time frame: 10 years

  3. Fracture Healing

    During follow up visits fracture healing will be evaluated

    Time frame: 10 years

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02728362
Lead sponsor
Spectrum Health Hospitals
Responsible party
Sponsor
First posted
Apr 5, 2016
Start date
Apr 2016
Primary completion
Jan 2019
Completion
Jan 2019
Last update
Oct 18, 2023

Study contacts

Blake W Miller, DO
principal investigator · Spectrum Health Hospitals

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion